Assessing the outcomes of prescribing angiotensin converting enzyme inhibitors and angiotensin receptor blockers for COVID-19 patients

BACKGROUND: Patients with heart failure were affected severely by COVID-19. Most heart failure patients are on guideline directed medical therapy, which includes ACE inhibitors (ACEI) and ARBs. These medications were controversial at the beginning of the pandemic due to their interplay with the rece...

Descripción completa

Detalles Bibliográficos
Autores principales: Mekary, Wissam, Fares, Souha, Abdulhai, Farah, Massoud, Gaelle, Refaat, Marwan, Mericskay, Mathias, Booz, George W., Zouein, Fouad A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472216/
https://www.ncbi.nlm.nih.gov/pubmed/37662725
http://dx.doi.org/10.1016/j.heliyon.2023.e19373

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472216/
https://www.ncbi.nlm.nih.gov/pubmed/37662725
http://dx.doi.org/10.1016/j.heliyon.2023.e19373

Ejemplares similares